A unique collection of patientderived blood cancer models in vivo ALL, NHL and AML an ex vivo ALL, AML, CML, CLL, patient-derived blood cancer models for efficacy testing.


HuKemia models are well-characterised and annotated with expression profiling data (U219) and gene copy (SNP6). MicroRNA, Exome sequencing, RNA-seq and Hotspot analysis available.

  • 14 Acute Lymphoblastic Leukemia, 2 Acute Myeloid Leukemia and 21 Lymphoma models.
  • Curated, online, searchable database (HuBaseTM) of phenotypic and genotypic data, patient information, growth curves and Standard of Care treatment
  • Patient-relevant mutations
  • Unique models for targeted therapy

Contact us today for free advice and support in choosing the most relevant models for your needs.